<DOC>
	<DOC>NCT01129427</DOC>
	<brief_summary>Primary objective: - Assess the effects of clopidogrel (300 mg loading dose followed by 4 days 75 mg/day) on Adenosine diphosphate (ADP)-induced platelet aggregation when given concomitantly with pantoprazole 80 mg/day compared to given alone in healthy male subjects - Compare the pharmacokinetic profiles of clopidogrel active metabolite when clopidogrel is given either alone or concomitantly with pantoprazole Secondary Objective: - Compare the pharmacokinetic profiles of clopidogrel when clopidogrel is given either alone or concomitantly with pantoprazole</brief_summary>
	<brief_title>Interaction Study of Clopidogrel 300/75 mg Given Alone or Concomitantly With Pantoprazole 80 mg in Healthy Subjects</brief_title>
	<detailed_description>The total study duration per subjects is 8 - 9 weeks broken down as follows: - Screening: 2 to 21 days before the first dosing - Period clopidogrel/placebo: 7 days including 5 days treatment - Period clopidogrel/placebo + pantoprazole: 14 days including 12 days treatment - Washout between periods: at least 14 days after last dosing with respect to clopidogrel treatment - End of study: 7 to 10 days after the last dosing</detailed_description>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Healthy male subject: as determined by medical history, physical examination including vital signs and clinical laboratory tests: with a body weight between 50 kg and 95 kg and with a Body Mass Index (BMI) between 18 and 30 kg/mÂ² Evidence of inherited disorder of coagulation/hemostasis functions Smoking more than 5 cigarettes or equivalent per day Abnormal hemostasis screen Unability to abstain from intake of any drug affecting hemostasis throughout the whole study duration Any contraindication to clopidogrel and/or pantoprazole The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>